American Society of Hirudotherapy

Hirudotherapy Atlas

730 curated entries across 5 evidence registries — unified entry point for clinicians, researchers, and policy analysts navigating the entire ASH knowledge base.

Last Updated: May 27, 2026ASH Editorial · based on the books
Conditions atlas — mixed Tier A/B/C: Off-label use means application outside the FDA-cleared indication. Clinical evidence (RCTs or systematic reviews) supports this use, but the FDA has not cleared it.Reference index: Content describes science, methodology, or organizational reference material — not a clinical efficacy claim.

730

Total registry entries across all 5 atlases

Conditions Atlas

174

Medical indications where hirudotherapy has been applied — tier-classified, ICD-10 coded, evidence-graded.

3

Tier A

7

Tier B

164

Tier C

Compound Reference

200

Salivary proteins, FDA-derived drugs, and reference anticoagulants — molecular targets, PubChem CIDs, RCSB PDB structures.

Spanning hirudin (1884) → modern direct thrombin/Xa inhibitors

Clinical Study & RCT Library

137

Clinical studies (17 randomized controlled trials, plus non-randomized trials, observational cohorts, case series, and reviews) — GRADE-rated certainty, PMID-linked, full Study Profile with n / intervention / endpoint.

17 RCTs (4,986 participants enrolled in the RCTs)

Biographies

64

Historical and contemporary figures whose work shaped hirudotherapy from biochemistry to clinical surgery.

172 key publications · Hippocrates → contemporary

Jurisdictions

155

Global regulatory bodies governing medicinal leech therapy — device clearance, drug classification, traditional medicine frameworks.

31 device-cleared · 9 traditional medicine

Research Library

20+

Long-form research articles, narrative reviews, systematic reviews, case series, and methodology essays.

Complements the structured registries above

How the registries cross-link

  • Each condition page lists detailed RCT entries investigating it (when present in the RCT Library)
  • Each RCT page links back to its condition page via a header chip
  • Each biography page lists the compounds the researcher influenced (cross-references to /compound/[slug])
  • Each jurisdiction page links to related jurisdictions in the same region or harmonization bloc
  • The global sitemap exposes all entries to search engines for full crawlability

Editorial integrity

All entries in these registries undergo PubMed PMID verification before inclusion. The ASH editorial policy explicitly forbids:

  • Fabricated PMIDs or placeholder citations
  • Plausible-sounding but unverifiable trial entries
  • Specific regulation codes without verified source
  • Quotes attributed to historical figures without primary source

Where uncertainty exists (e.g., a regulator's specific leech-therapy stance), entries are honestly marked as "unregulated" with explicit notes — never inflated to a status we cannot defend.

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.